Should I Buy VTAK? VTAK 2026 Analysis

Should You Buy Catheter Precision Inc (VTAK) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

2.080

1 Day change

-0.48%

52 Week Range

15.680

Analysis Updated At

2026/01/26

Catheter Precision Inc (VTAK) is not a strong buy at this moment for a beginner investor with a long-term strategy. The lack of significant trading trends, neutral insider and hedge fund sentiment, absence of recent news or catalysts, and weak financial performance make it unsuitable for immediate investment. While the technical indicators show some positive momentum, they are not strong enough to justify a buy decision for a long-term investor.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 68.42, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 2.154, with resistance at 2.305 and support at 2.003. Overall, the technical indicators suggest mild bullishness but not a strong buy signal.

Options Data

Positive Catalysts

Revenue increased by 135.42% YoY in Q3 2025, and gross margin improved to 92.04%, up 2.75% YoY. These are positive signs of operational efficiency.

Neutral/Negative Catalysts

Net income dropped significantly by -45.36% YoY, and EPS fell by -95.55% YoY, indicating poor profitability. No recent news, insider activity, or hedge fund interest to drive the stock higher. Congress trading data is also absent.

Financial Performance

In Q3 2025, revenue grew significantly by 135.42% YoY to $226,000. However, net income dropped to -$2,251,000 (-45.36% YoY), and EPS fell sharply to -1.7 (-95.55% YoY). Gross margin improved slightly to 92.04% (+2.75% YoY), but the overall financial performance remains weak due to declining profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available for VTAK.

Analyst Rating

Wall Street analysts forecast VTAK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VTAK is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 2.090

Low

Averages

High